ZNF563 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.514200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.489000E-01
Normal-vs-Stage2
4.519900E-02
Normal-vs-Stage3
9.241800E-02
Normal-vs-Stage4
2.191200E-01
Stage1-vs-Stage2
4.152400E-01
Stage1-vs-Stage3
6.174500E-02
Stage1-vs-Stage4
3.488800E-01
Stage2-vs-Stage3
1.382850E-01
Stage2-vs-Stage4
6.700600E-01
Stage3-vs-Stage4
3.466200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.260100E-02
Normal-vs-AfricanAmerican
1.259570E-01
Normal-vs-Asian
4.853800E-02
Caucasian-vs-AfricanAmerican
3.011000E-01
Caucasian-vs-Asian
2.267400E-01
AfricanAmerican-vs-Asian
9.056000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.620500E-02
Normal-vs-Female
3.461900E-02
Male-vs-Female
8.604000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.682400E-01
Normal-vs-Age(41-60Yrs)
4.037800E-01
Normal-vs-Age(61-80Yrs)
5.677900E-02
Normal-vs-Age(81-100Yrs)
9.907800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.952600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.057800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.335000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.665000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.987200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.909000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.747500E-02
Normal-vs-Daily Drinker
2.535600E-02
Normal-vs-Weekly Drinker
5.562200E-02
Normal-vs-Occasional Drinker
4.146600E-01
Normal-vs-Social Drinker
1.409210E-01
Non Drinker-vs-Daily Drinker
1.585600E-01
Non Drinker-vs-Weekly Drinker
3.282000E-01
Non Drinker-vs-Occasional Drinker
6.854000E-01
Non Drinker-vs-Social Drinker
8.154400E-01
Daily Drinker-vs-Weekly Drinker
8.149800E-01
Daily Drinker-vs-Occasional Drinker
6.309800E-02
Daily Drinker-vs-Social Drinker
1.425590E-01
Weekly Drinker-vs-Occasional Drinker
1.483230E-01
Weekly Drinker-vs-Social Drinker
2.727400E-01
Occasional Drinker-vs-Social Drinker
8.976800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.205830E-01
Normal-vs-Grade 2
6.564300E-02
Normal-vs-Grade 3
1.152420E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.753400E-01
Grade 1-vs-Grade 3
7.224800E-01
Grade 1-vs-Grade 4
1.205830E-01
Grade 2-vs-Grade 3
8.943600E-01
Grade 2-vs-Grade 4
6.564300E-02
Grade 3-vs-Grade 4
1.152420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.205900E-02
Normal-vs-NonDiabetic
3.193600E-02
Diabetic-vs-NonDiabetic
7.464600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.424400E-02
Normal-vs-NoPancreatitis
2.756300E-02
Pancreatitis-vs-NoPancreatitis
5.135200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.940400E-02
Normal-vs-N1
5.724200E-02
N0-vs-N1
5.027200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.796400E-01
Normal-vs-TP53-NonMutant
3.208000E-01
TP53-Mutant-vs-TP53-NonMutant
2.472800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
